Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Dynamix Pharmaceuticals Logo
Dynamix Pharmaceuticals Growth Score
82
CB Rank
1094497
Heat Score
57
Dynamix Pharmaceuticals is a biopharmaceutical company that discovers and develops drugs for cancer and autoimmune disorders.
Founded
obfuscation
Private Rehovot, HaMerkaz, Israel11-50 www.dynxp.com
Biopharma
Clinical Trials
Pharmaceutical
Overview

Dynamix Pharmaceuticals
Growth Score
82
Heat Score
57

Growth Score82
-3 pts
in past quarter
Heat Score 57
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Dynamix Pharmaceuticals

CB Rank
1094497
Dynamix Pharmaceuticals is a biopharmaceutical company that discovers and develops drugs for cancer and autoimmune disorders.
Founded
obfuscation
Private Rehovot, HaMerkaz, Israel11-50 www.dynxp.com
Biopharma
Clinical Trials
Pharmaceutical

Key People

Details

Legal Name Dynamix Pharmaceuticals Ltd.
Operating Status Active
Company Type For Profit
Founders  Oren Becker
Phone Number +972 8 9395010
Contact Email info@dynxp.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

DynamixFit™ Technology
An in silico platform that addresses induced fit challenges in structure-based drug design to aid rapid drug candidate discovery and optimization.
Type II Kinase Inhibitors
Selective small molecule inhibitors targeting Type II kinases for use in cancer and autoimmune disorder therapies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

173

Active Website Tech Count

7Dynamix Pharmaceuticals is actively using 7 technologies for its website, according to BuiltWith. These include Cloudflare CDN, Cloudflare, and  Cloudflare Network Error Logging.

Total IP

2The intellectual property of Dynamix Pharmaceuticals includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Dynamix Pharmaceuticals's headquarters? Dynamix Pharmaceuticals is located in Rehovot, HaMerkaz, Israel.Who are Dynamix Pharmaceuticals's competitors? Alternatives and possible competitors to Dynamix Pharmaceuticals may include Pfizer, Madrigal Pharmaceuticals, and  Karyopharm Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|